Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
05/08/2003 | US20030087435 Catalytic antibodies raised against sarin; an organophosphorous anticholinesterase, and an antigen and process for the preparation thereof |
05/08/2003 | US20030087421 Lawsonia intracellularis |
05/08/2003 | US20030087412 Nucleotide sequences coding polypeptide for use in the prevention and treatment of tumors, nervous system, cardiomyopathy, viral and metabolic diseases |
05/08/2003 | US20030087395 Nucleotide sequences coding polypepide for use in the treatment of cardiovascular and immunological disorders |
05/08/2003 | US20030087393 Endostatin for use in the treatment of cancer and tumor metastasis |
05/08/2003 | US20030087385 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment of tumor and cell proliferation disorders |
05/08/2003 | US20030087384 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment fibroblast growth factor receptor defects |
05/08/2003 | US20030087382 25501, a human transferase family member and uses therefor |
05/08/2003 | US20030087379 Measurement of dimerization of viral polymerase; obtain sample containing viral dimerized proteins, incubate with binding agent, determine the amount of complex formed |
05/08/2003 | US20030087378 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cancer, psoriasis and nervous system disorders |
05/08/2003 | US20030087377 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cancer, psoriasis and nervous system disorders |
05/08/2003 | US20030087376 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment of tumor and cell proliferation disorders |
05/08/2003 | US20030087375 Sperm specific proteins |
05/08/2003 | US20030087372 Methods of culturing animal cells and polypeptide production in animal cells |
05/08/2003 | US20030087371 Modulatory proteins of human CNS receptors |
05/08/2003 | US20030087368 Cloning and sequencing of pyruvate decarboxylase (PDC) genes from bacteria and uses therefor |
05/08/2003 | US20030087367 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/08/2003 | US20030087366 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders |
05/08/2003 | US20030087365 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders |
05/08/2003 | US20030087364 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders |
05/08/2003 | US20030087363 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/08/2003 | US20030087362 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/08/2003 | US20030087361 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/08/2003 | US20030087360 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders |
05/08/2003 | US20030087359 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders |
05/08/2003 | US20030087358 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders |
05/08/2003 | US20030087357 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/08/2003 | US20030087356 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders |
05/08/2003 | US20030087355 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders |
05/08/2003 | US20030087354 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders |
05/08/2003 | US20030087353 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/08/2003 | US20030087352 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/08/2003 | US20030087351 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/08/2003 | US20030087350 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/08/2003 | US20030087349 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/08/2003 | US20030087348 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders |
05/08/2003 | US20030087347 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders |
05/08/2003 | US20030087346 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/08/2003 | US20030087345 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/08/2003 | US20030087343 Novel SLGP nucleic acid molecules and uses therefor |
05/08/2003 | US20030087341 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of autoimmune disease |
05/08/2003 | US20030087339 Alzheimer's disease; Parkinson's disease; rheumatic disorders |
05/08/2003 | US20030087324 Immortalized cell pool for use in genrating monoclonal antibodies for use as tools in the detection of nervous system disorders |
05/08/2003 | US20030087323 Specific monoclonal antibody against terbinafine |
05/08/2003 | US20030087318 Antibodies against an extracellular matrix complex and their use in the detection of cancer |
05/08/2003 | US20030087314 Immunogenic composition for use in the diagnosis of allergies in mammals |
05/08/2003 | US20030087312 Monoclonal antibody for use in the detection of mammary gland cancer |
05/08/2003 | US20030087306 Methods for identifying novel multimeric agents that modulate receptors |
05/08/2003 | US20030087305 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders |
05/08/2003 | US20030087304 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders |
05/08/2003 | US20030087299 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
05/08/2003 | US20030087294 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins and uses thereof |
05/08/2003 | US20030087270 Nucleotide sequences coding polypeptide for use in the detection, classification, prevention and treatment of human cervical cancers |
05/08/2003 | US20030087266 IGs as modifiers of the p53 pathway and methods of use |
05/08/2003 | US20030087252 Novel compositions and methods in cancer associated with altered expression of PRDM11 |
05/08/2003 | US20030087249 93870, a human G-protein coupled receptor and uses therefor |
05/08/2003 | US20030087246 Nucleic acids of the human ABCA12 gene, vectors containing such nucleic acids and uses thereof |
05/08/2003 | US20030087236 Method for generating diversity |
05/08/2003 | US20030086942 Inhibition of nucleocytoplasmic transport by vesicular stomatitis virus M protein-like polypeptides |
05/08/2003 | US20030086941 For diagnosing and therapy of gastrin-dependent tumor |
05/08/2003 | US20030086939 Methods to improve immunogenicity of antigens and specificity of antibodies |
05/08/2003 | US20030086936 For use in hematopoietic therapy; for arresting proliferation of leukemic cells |
05/08/2003 | US20030086934 Basal cell markers in breast cancer and uses thereof |
05/08/2003 | US20030086932 For use in downmodulation or upmodulation of the immune response; for preparing an allogeinc cell for transplantation |
05/08/2003 | US20030086931 Therapy of cancers |
05/08/2003 | US20030086930 Administering CTLA-4 (cytotoxic T lymphocyte antigen-4) antibodies for therapy of cancer |
05/08/2003 | US20030086929 Administering inhibitor of ATP synthase activity in a pharmaceutically effective amount for therapy and prophylaxis of prostate cancer |
05/08/2003 | US20030086928 For use in therapy |
05/08/2003 | US20030086927 Administering to a host an agent which inhibits cyclin G1 protein, agent being administered in amount effective to inhibit cyclin G1 protein in tumor cells of host |
05/08/2003 | US20030086925 Treatment of autoimmune diseases |
05/08/2003 | US20030086924 Treatment with anti-ErbB2 antibodies |
05/08/2003 | US20030086922 Administering a bispecific antibody comprising a first binding site capable of recognizing and binding a first antigen Fc gamma RIII and second binding site capable of recognizing and binding a second antigen |
05/08/2003 | US20030086921 For therapy and prophylaxis of allergic conditions, autoimmune diseases and inflammatory diseases |
05/08/2003 | US20030086919 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor |
05/08/2003 | CA2465367A1 Diagnosis and treatment of infectious diseases through indel-differentiated proteins |
05/08/2003 | CA2465325A1 Antibodies for inhibiting blood coagulation and methods of use thereof |
05/08/2003 | CA2465314A1 Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents |
05/08/2003 | CA2465040A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
05/08/2003 | CA2464940A1 Pyranosone dehydratase from phanerochaete chrysosporium |
05/08/2003 | CA2462660A1 Nucleic acid-associated proteins |
05/07/2003 | EP1308730A1 Method of detecting or assaying hbv |
05/07/2003 | EP1308514A2 ICAM-4 Materials and Methods |
05/07/2003 | EP1308507A2 HCV anti-core monoclonal antibodies |
05/07/2003 | EP1308461A2 Antibodies to beta-amyloids or their derivatives and use thereof |
05/07/2003 | EP1308456A2 Antibody purification by ion exchange chromatography |
05/07/2003 | EP1308455A2 A composition comprising anti-HER2 antibodies |
05/07/2003 | EP1308168A1 Novel remedies for cancer |
05/07/2003 | EP1307568A2 Metalloproteinase-disintegrin polypeptides and methods of making and use thereof |
05/07/2003 | EP1307566A2 Mitogen activated kinase |
05/07/2003 | EP1307564A2 Compounds and methods for treatment and diagnosis of chlamydial infection |
05/07/2003 | EP1307561A2 Nucleic acids, with the aid of which plants having an altered metabolite content can be produced |
05/07/2003 | EP1307560A2 Schizophrenia related gene and protein |
05/07/2003 | EP1307559A2 Slit-like protein obtained from a cdna library from hs-5 stromal cell line |
05/07/2003 | EP1307557A2 Endothelial cell expression patterns |
05/07/2003 | EP1307554A2 C3b/c4b complement receptor-like molecules and uses thereof |
05/07/2003 | EP1307553A2 Mammalian dna binding membrane-associated protein-encoding gene and uses |
05/07/2003 | EP1307552A2 C3b/C4b COMPLEMENT RECEPTOR-LIKE MOLECULES AND USES THEREOF |
05/07/2003 | EP1307546A2 Ampk-related serine/threonine kinase, designated snark |
05/07/2003 | EP1307537A1 Neospora caninum isolate |
05/07/2003 | EP1307490A1 F v? constructs with an influenceable affinity for a substance that is to be linked |